HDAC9 and bone cancer: Moreover, HDAC inhibitors trichostatin A and suberoylanilide hydroxamic acid modulate C-fiber sensitivity by increasing histone acetylation in a nerve injury animal model [79], and these HDAC inhibitors also produce pain relief in a bone cancer pain rat model [77, 80] and enhance morphine analgesia [77].